20 June 2013
Keywords: cor, integrelin, phase, ii, results, therapeutics, usa
Article | 14 June 1993
Cor Therapeutics of the USA has presented preliminary data from a Phase
II study of its platelet aggregation inhibitor, Integrelin ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 June 1993
7 June 1993
19 June 2013
© 2013 thepharmaletter.com